Carregant...

The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus

BACKGROUND: Sodium glucose co‐transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta‐cell function or the degree of insulin resistance, giving these ag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Pract
Autor principal: Brunton, S. A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758393/
https://ncbi.nlm.nih.gov/pubmed/26147213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12675
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!